Percutaneous ablation of peribiliary tumors with irreversible electroporation

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 1, 2014, Pages 112-118

  Silk, Mikhail T ^a   Wimmer, Thomas ^a,b   Lee, Kyungmouk S ^a   Srimathveeravalli, Govindarajan ^a   Brown, Karren T ^a   Kingham, Peter T ^a   Fong, Yuman ^a   Durack, Jeremy C ^a   Sofocleous, Constantinos T ^a   Solomon, Stephen B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; IOHEXOL; BIOLOGICAL MARKER;

ABLATION THERAPY; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILE DUCT DILATATION; BILIARY STENT; BILIRUBIN BLOOD LEVEL; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL METASTASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIGESTIVE SYSTEM TUMOR; ELECTRODE; FEMALE; FOLLOW UP; HEMANGIOPERICYTOMA; HEPATIC DUCT; HUMAN; IRREVERSIBLE ELECTROPORATION; IRREVERSIBLE ELECTROPORATION DEVICE; LIVER METASTASIS; LIVER RESECTION; LIVER TUMOR; MALE; MEDICAL RECORD REVIEW; METAL STENT; METASTASIS; MICROWAVE THERAPY; MIDDLE AGED; PANCREAS CARCINOMA; PERIBILIARY TUMOR; PET-CT SCANNER; PRIORITY JOURNAL; PULSE GENERATOR; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; TREATMENT FAILURE; TUMOR ABLATION; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; VERY ELDERLY; ADVERSE EFFECTS; BLOOD; CHOLESTASIS; DISEASE COURSE; ELECTROPORATION; INJURIES; LIVER NEOPLASMS; PATHOLOGY; RADIOGRAPHY; SECONDARY; TIME; TREATMENT OUTCOME;

ABLATION TECHNIQUES; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BILIRUBIN; BIOMARKERS; CHOLESTASIS; DISEASE PROGRESSION; ELECTROPORATION; FEMALE; HEPATIC DUCT, COMMON; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84895970378     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.10.012     Document Type: Article

References (28)

1. J.G. Fortner, J.S. Silva, R.B. Golbey, E.B. Cox, and B.J. Maclean Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection Ann Surg 199 1984 306 316
2. G. Steele Jr, and T.S. Ravikumar Resection of hepatic metastases from colorectal cancer: biologic perspectives Ann Surg 210 1989 127 138
3. J.S. Wagner, M.A. Adson, J.A. Van Heerden, M.H. Adson, and D.M. Ilstrup The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment Ann Surg 199 1984 502 508
4. D.A. Gervais, S.N. Goldberg, D.B. Brown, M.C. Soulen, S.F. Millward, and D.K. Rajan Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors J Vasc Interv Radiol 20 2009 3 8
5. L. Crocetti, T. de Baere, and R. Lencioni Quality improvement guidelines for radiofrequency ablation of liver tumours Cardiovasc Intervent Radiol 33 2010 11 17
6. R.V. Davalos, I.L. Mir, and B. Rubinsky Tissue ablation with irreversible electroporation Ann Biomed Eng 33 2005 223 231
7. E. Maor, A. Ivorra, J. Leor, and B. Rubinsky The effect of irreversible electroporation on blood vessels Technol Cancer Res Treat 6 2007 307 312
8. E.W. Lee, C.T. Loh, and S.T. Kee Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation Technol Cancer Res Treat 6 2007 287 294
9. K.P. Charpentier, F. Wolf, L. Noble, B. Winn, M. Resnick, and D.E. Dupuy Irreversible electroporation of the liver and liver hilum in swine HPB 13 2011 168 173
10. K.R. Thomson, W. Cheung, and S.J. Ellis et al. Investigation of the safety of irreversible electroporation in humans J Vasc Interv Radiol 22 2011 611 621
11. G. Narayanan, P.J. Hosein, and G. Arora et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma J Vasc Interv Radiol 23 2012 1613 1621
12. T.P. Kingham, A.M. Karkar, and M.I. D'Angelica et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation J Am Coll Surg 215 2012 379 387
13. R. Cannon, S. Ellis, D. Hayes, G. Narayanan, and R.C. Martin 2nd Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures J Surg Oncol 107 2013 544 549
14. E.R. Ryan, C.T. Sofocleous, and H. Schoder et al. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness Radiology 268 2013 288 295
15. D. Longo, A. Fauci, D. Kasper, S. Hauser, J. Jameson, and J. Loscalzo Harrison's Principles of Internal Medicine 18th ed 2011 McGraw-Hill New York
16. B. Rubinsky, G. Onik, and P. Mikus Irreversible electroporation: a new ablation modality - clinical implications Technol Cancer Res Treat 6 2007 37 48
17. H.B. Kim, C.K. Sung, and K.Y. Baik et al. Changes of apoptosis in tumor tissues with time after irreversible electroporation Biochem Biophys Res Commun 435 2013 651 656
18. E.W. Lee, C. Chen, V.E. Prieto, S.M. Dry, C.T. Loh, and S.T. Kee Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation Radiology 255 2010 426 433
19. S. Bagla, and D. Papadouris Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report J Vasc Interv Radiol 23 2012 142 145
20. R.C. Martin 2nd, K. McFarland, S. Ellis, and V. Velanovich Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma J Am Coll Surg 215 2012 361 369
21. M. Usman, W. Moore, R. Talati, K. Watkins, and T.V. Bilfinger Irreversible electroporation of lung neoplasm: a case series Med Sci Monit 18 2012 CS43 CS47
22. M. Faroja, M. Ahmed, and L. Appelbaum et al. Irreversible electroporation ablation: is all the damage nonthermal? Radiology 266 2013 462 470
23. R.V. Davalos, and B. Rubinsky Temperature considerations during irreversible electroporation Int J Heat Mass Transfer 51 2008 5617 5622
24. E.O. Olweny, P. Kapur, Y.K. Tan, S.K. Park, M. Adibi, and J.A. Cadeddu Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney Urology 81 2013 679 684
25. E. Berber, and A.E. Siperstein Perioperative outcome after laparoscopic radiofrequency ablation of liver tumors: an analysis of 521 cases Surg Endosc 21 2007 613 618
26. C. Kanthou, S. Kranjc, G. Sersa, G. Tozer, A. Zupanic, and M. Cemazar The endothelial cytoskeleton as a target of electroporation-based therapies Mol Cancer Ther 5 2006 3145 3152
27. L. Crocetti, T. De Baere, and R. Lencioni Quality improvement guidelines for radiofrequency ablation of liver tumours Cardiovasc Intervent Radiol 33 2010 11 17
28. E. Ben-David, M. Ahmed, and M. Faroja et al. Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties Radiology In press available online July 11, 2013